Report Detail
Global Retrovirus-Based Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4588841 |
- 21 May, 2024 |
- Global |
- 98 Pages |
- GIR (Global Info Research) |
- Other
Retrovirus-based gene therapy drugs are drugs that use retroviruses as vectors to introduce normal or modified genes into patient cells to treat genetic diseases, cancer and other diseases. Retroviruses occur naturally in some animals and can reverse-transcribe RNA into DNA and insert into the genome of host cells. In gene therapy, scientists take advantage of this feature to load therapeutic genes into retroviral vectors, allowing them to enter the patient's cells and express the required proteins to achieve therapeutic purposes.
According to our (Global Info Research) latest study, the global Retrovirus-Based Gene Therapy Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Retrovirus-Based Gene Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Retrovirus-Based Gene Therapy Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global Retrovirus-Based Gene Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Retrovirus-Based Gene Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Retrovirus-Based Gene Therapy Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Retrovirus-Based Gene Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Retrovirus-Based Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Chaselection, MolMed, GILD, Denovo Biopharma, Pfizer, Epeius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Retrovirus-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Retrovirus-Based Gene Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CAR-T Therapy
Autologous CD34+ Cell Gene Therapy
Market segment by Application
Hospital
Diagnostic and Testing Laboratories
Academic and Research Organizations
Others
Market segment by players, this report covers
GSK
Chaselection
MolMed
GILD
Denovo Biopharma
Pfizer
Epeius
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Retrovirus-Based Gene Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Retrovirus-Based Gene Therapy Drugs, with revenue, gross margin, and global market share of Retrovirus-Based Gene Therapy Drugs from 2019 to 2024.
Chapter 3, the Retrovirus-Based Gene Therapy Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Retrovirus-Based Gene Therapy Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Retrovirus-Based Gene Therapy Drugs.
Chapter 13, to describe Retrovirus-Based Gene Therapy Drugs research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Retrovirus-Based Gene Therapy Drugs by Type
- 1.3.1 Overview: Global Retrovirus-Based Gene Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Retrovirus-Based Gene Therapy Drugs Consumption Value Market Share by Type in 2023
- 1.3.3 CAR-T Therapy
- 1.3.4 Autologous CD34+ Cell Gene Therapy
- 1.4 Global Retrovirus-Based Gene Therapy Drugs Market by Application
- 1.4.1 Overview: Global Retrovirus-Based Gene Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Diagnostic and Testing Laboratories
- 1.4.4 Academic and Research Organizations
- 1.4.5 Others
- 1.5 Global Retrovirus-Based Gene Therapy Drugs Market Size & Forecast
- 1.6 Global Retrovirus-Based Gene Therapy Drugs Market Size and Forecast by Region
- 1.6.1 Global Retrovirus-Based Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Retrovirus-Based Gene Therapy Drugs Market Size by Region, (2019-2030)
- 1.6.3 North America Retrovirus-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
- 1.6.4 Europe Retrovirus-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
- 1.6.6 South America Retrovirus-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 GSK
- 2.1.1 GSK Details
- 2.1.2 GSK Major Business
- 2.1.3 GSK Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.1.4 GSK Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 GSK Recent Developments and Future Plans
- 2.2 Chaselection
- 2.2.1 Chaselection Details
- 2.2.2 Chaselection Major Business
- 2.2.3 Chaselection Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.2.4 Chaselection Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Chaselection Recent Developments and Future Plans
- 2.3 MolMed
- 2.3.1 MolMed Details
- 2.3.2 MolMed Major Business
- 2.3.3 MolMed Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.3.4 MolMed Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 MolMed Recent Developments and Future Plans
- 2.4 GILD
- 2.4.1 GILD Details
- 2.4.2 GILD Major Business
- 2.4.3 GILD Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.4.4 GILD Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 GILD Recent Developments and Future Plans
- 2.5 Denovo Biopharma
- 2.5.1 Denovo Biopharma Details
- 2.5.2 Denovo Biopharma Major Business
- 2.5.3 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.5.4 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Denovo Biopharma Recent Developments and Future Plans
- 2.6 Pfizer
- 2.6.1 Pfizer Details
- 2.6.2 Pfizer Major Business
- 2.6.3 Pfizer Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.6.4 Pfizer Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Pfizer Recent Developments and Future Plans
- 2.7 Epeius
- 2.7.1 Epeius Details
- 2.7.2 Epeius Major Business
- 2.7.3 Epeius Retrovirus-Based Gene Therapy Drugs Product and Solutions
- 2.7.4 Epeius Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Epeius Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Retrovirus-Based Gene Therapy Drugs Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Retrovirus-Based Gene Therapy Drugs by Company Revenue
- 3.2.2 Top 3 Retrovirus-Based Gene Therapy Drugs Players Market Share in 2023
- 3.2.3 Top 6 Retrovirus-Based Gene Therapy Drugs Players Market Share in 2023
- 3.3 Retrovirus-Based Gene Therapy Drugs Market: Overall Company Footprint Analysis
- 3.3.1 Retrovirus-Based Gene Therapy Drugs Market: Region Footprint
- 3.3.2 Retrovirus-Based Gene Therapy Drugs Market: Company Product Type Footprint
- 3.3.3 Retrovirus-Based Gene Therapy Drugs Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Retrovirus-Based Gene Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Retrovirus-Based Gene Therapy Drugs Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Retrovirus-Based Gene Therapy Drugs Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Retrovirus-Based Gene Therapy Drugs Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Retrovirus-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
- 6.2 North America Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2030)
- 6.3 North America Retrovirus-Based Gene Therapy Drugs Market Size by Country
- 6.3.1 North America Retrovirus-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
- 6.3.2 United States Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 6.3.3 Canada Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Retrovirus-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
- 7.2 Europe Retrovirus-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
- 7.3 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country
- 7.3.1 Europe Retrovirus-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
- 7.3.2 Germany Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 7.3.3 France Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 7.3.5 Russia Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 7.3.6 Italy Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size by Region
- 8.3.1 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Consumption Value by Region (2019-2030)
- 8.3.2 China Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 8.3.3 Japan Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 8.3.5 India Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 8.3.7 Australia Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Retrovirus-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
- 9.2 South America Retrovirus-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
- 9.3 South America Retrovirus-Based Gene Therapy Drugs Market Size by Country
- 9.3.1 South America Retrovirus-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Country
- 10.3.1 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
- 10.3.4 UAE Retrovirus-Based Gene Therapy Drugs Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Retrovirus-Based Gene Therapy Drugs Market Drivers
- 11.2 Retrovirus-Based Gene Therapy Drugs Market Restraints
- 11.3 Retrovirus-Based Gene Therapy Drugs Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Retrovirus-Based Gene Therapy Drugs Industry Chain
- 12.2 Retrovirus-Based Gene Therapy Drugs Upstream Analysis
- 12.3 Retrovirus-Based Gene Therapy Drugs Midstream Analysis
- 12.4 Retrovirus-Based Gene Therapy Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Retrovirus-Based Gene Therapy Drugs. Industry analysis & Market Report on Retrovirus-Based Gene Therapy Drugs is a syndicated market report, published as Global Retrovirus-Based Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Retrovirus-Based Gene Therapy Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
